The latest price target for Amdocs (NASDAQ:DOX) was reported by Barclays on November 14, 2024. The analyst firm set a price target for $111.00 expecting DOX to rise to within 12 months (a possible 29.57% upside). 8 analyst firms have reported ratings in the last year.

The latest analyst rating for Amdocs (NASDAQ:DOX) was provided by Barclays, and Amdocs maintained their overweight rating.

The last upgrade for Amdocs Ltd happened on May 16, 2023 when Barclays raised their price target to $115. Barclays previously had an equal-weight for Amdocs Ltd.

The last downgrade for Amdocs Ltd happened on December 14, 2021 when JP Morgan changed their price target from $91 to $86 for Amdocs Ltd.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amdocs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amdocs was filed on November 14, 2024 so you should expect the next rating to be made available sometime around November 14, 2025.

While ratings are subjective and will change, the latest Amdocs (DOX) rating was a maintained with a price target of $113.00 to $111.00. The current price Amdocs (DOX) is trading at is $85.67, which is out of the analyst’s predicted range.